Stocks Health care CING
NASDAQ · Health careCingulate Inc. (CING)
It posted a net loss of $28.8M. In fiscal 2025 capital spending exceeded operating cash flow by $17.4M. At June 30, 2026 it held $28.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What Cingulate Inc. does
Cingulate Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CING.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$22.4M | -$4.44 | -$17.4M |
| 2024 | n/a | -$16.6M | -$10.86 | -$18.7M |
| 2023 | n/a | -$23.5M | -$332.18 | -$15.3M |
| 2022 | n/a | -$17.7M | -$374.98 | -$16M |
| 2021 | n/a | -$20.7M | -$35.65 | -$11.2M |
| 2021 | n/a | -$7.2M | n/a | -$7.2M |
Latest SEC filings
What Cingulate Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026
- August 13, 2026
- July 23, 2026
- July 15, 2026
- July 14, 2026
- July 2, 2026
- June 16, 2026
- June 2, 2026
- May 29, 2026Proxy statement DEF 14A
- May 29, 2026
Questions about CING
What does Cingulate Inc. do?
Cingulate Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CING.
Is Cingulate Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $28.8M.
When did Cingulate Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026.
Similar companies
Follow CING
Get an email when Cingulate Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow CING: get an email when it filesWhere the numbers come from
Financial figures are the values Cingulate Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.